[AsCNP_O1] Oral Session 1
Dementia & Neurological Disorders

[AsCNP-O1-5] Development of novel strategies for genetic analysis and drug discovery for the familial and sporadic dopamine-related disorders

^○Ichiro KAWAHATA¹, Kyoko HOSHINO², Kazuko HASEGAWA³, Hiroshi ICHINOSE⁴, Kazuto KOBAYASHI⁵, Kohji FUKUNAGA¹ (1. Lab of Pharmacology, Grad Sch of Pharm Sci, Tohoku University, Sendai, Japan, 2. Segawa Memorial Neurological Clinic for Children, Tokyo, Japan, 3. Neurology, Sagamihara National Hospital, Kanagawa, Japan, 4. Grad Sch of Biosci, Tokyo Institute of Technology, Kanagawa, Japan, 5. Dept Mol Gen, Fukushima Medical University, Fukushima, Japan)